Literature DB >> 8436191

The T cell receptor alpha beta V-J shuffling shows lack of autonomy between the combining site and the constant domain of the receptor chains.

G Casorati1, A Traunecker, K Karjalainen.   

Abstract

In order to assess the structural independence of the T cell receptor (TCR) combining site from the rest of the molecule we have generated two recombinant chains consisting of a TCR V-J alpha region linked to the C beta and a TCR V-J beta linked to the C alpha. If the V and C domains of the TCR form independent domains, as has been shown for the Ig molecules, we would expect to obtain a functional chimeric TCR. Interestingly, it was found that the shuffled molecules are produced intracellularly in T cell hybridomas, but are not expressed on the cell surface. To explain this failure of the shuffled molecules we propose that the TCR has a more compact structure, compared to the Ig, and that it is indispensable to keep a longitudinal inter-domain contact between the V-J and C portion to have a functional molecule.

Mesh:

Substances:

Year:  1993        PMID: 8436191     DOI: 10.1002/eji.1830230246

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  Structural mutations in the constant region of the T-cell antigen receptor (TCR)beta chain and their effect on TCR alpha and beta chain interaction.

Authors:  Z G Li; W P Wu; N Manolios
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

2.  Cloning and comparative analysis of the human pre-T-cell receptor alpha-chain gene.

Authors:  P Del Porto; L Bruno; M G Mattei; H von Boehmer; C Saint-Ruf
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

3.  A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel.

Authors:  Katharina Gamerdinger; Corinne Moulon; David R Karp; Jeroen Van Bergen; Frits Koning; Doris Wild; Ulrike Pflugfelder; Hans Ulrich Weltzien
Journal:  J Exp Med       Date:  2003-05-19       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.